BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vocka M, Langer D, Fryba V, Petrtyl J, Hanus T, Kalousova M, Zima T, Petruzelka L. Novel serum markers HSP60, CHI3L1, and IGFBP-2 in metastatic colorectal cancer. Oncol Lett 2019;18:6284-92. [PMID: 31788106 DOI: 10.3892/ol.2019.10925] [Cited by in Crossref: 5] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Gligorijević N, Dobrijević Z, Šunderić M, Robajac D, Četić D, Penezić A, Miljuš G, Nedić O. The Insulin-like Growth Factor System and Colorectal Cancer. Life (Basel) 2022;12:1274. [PMID: 36013453 DOI: 10.3390/life12081274] [Reference Citation Analysis]
2 Inigo JR, Chandra D. The mitochondrial unfolded protein response (UPRmt): shielding against toxicity to mitochondria in cancer. J Hematol Oncol 2022;15:98. [PMID: 35864539 DOI: 10.1186/s13045-022-01317-0] [Reference Citation Analysis]
3 Cyran AM, Zhitkovich A. Heat Shock Proteins and HSF1 in Cancer. Front Oncol 2022;12:860320. [PMID: 35311075 DOI: 10.3389/fonc.2022.860320] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
4 Vekic J, Zeljkovic A, Stefanovic A, Giglio RV, Ciaccio M, Rizzo M. Diabetes and Colorectal Cancer Risk: A New Look at Molecular Mechanisms and Potential Role of Novel Antidiabetic Agents. Int J Mol Sci 2021;22:12409. [PMID: 34830295 DOI: 10.3390/ijms222212409] [Reference Citation Analysis]
5 Tieng FYF, Abu N, Nasir SN, Lee LH, Ab Mutalib NS. Liquid Biopsy-Based Colorectal Cancer Screening via Surface Markers of Circulating Tumor Cells. Diagnostics (Basel) 2021;11:2136. [PMID: 34829483 DOI: 10.3390/diagnostics11112136] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Abi Zamer B, El-Huneidi W, Eladl MA, Muhammad JS. Ins and Outs of Heat Shock Proteins in Colorectal Carcinoma: Its Role in Carcinogenesis and Therapeutic Perspectives. Cells 2021;10:2862. [PMID: 34831085 DOI: 10.3390/cells10112862] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Guo J, Zhu S, Deng H, Xu R. HSP60-knockdown suppresses proliferation in colorectal cancer cells via activating the adenine/AMPK/mTOR signaling pathway. Oncol Lett 2021;22:630. [PMID: 34267822 DOI: 10.3892/ol.2021.12891] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
8 Álvarez-Artime A, García-Soler B, Sainz RM, Mayo JC. Emerging Roles for Browning of White Adipose Tissue in Prostate Cancer Malignant Behaviour. Int J Mol Sci 2021;22:5560. [PMID: 34074045 DOI: 10.3390/ijms22115560] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
9 Kalita B, Coumar MS. Deciphering molecular mechanisms of metastasis: novel insights into targets and therapeutics. Cell Oncol (Dordr) 2021;44:751-75. [PMID: 33914273 DOI: 10.1007/s13402-021-00611-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ray AM, Salim N, Stevens M, Chitre S, Abdeen S, Washburn A, Sivinski J, O'Hagan HM, Chapman E, Johnson SM. Exploiting the HSP60/10 chaperonin system as a chemotherapeutic target for colorectal cancer. Bioorg Med Chem 2021;40:116129. [PMID: 33971488 DOI: 10.1016/j.bmc.2021.116129] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
11 Jin MH, Nam AR, Bang JH, Oh KS, Seo HR, Kim JM, Yoon J, Kim TY, Oh DY. WEE1 inhibition reverses trastuzumab resistance in HER2-positive cancers. Gastric Cancer 2021;24:1003-20. [PMID: 33723720 DOI: 10.1007/s10120-021-01176-7] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
12 Bi F, Wang J, Zheng X, Xiao J, Zhi C, Gu J, Zhang Y, Li J, Miao Z, Wang Y, Li Y. HSP60 participates in the anti-glioma effects of curcumin. Exp Ther Med 2021;21:204. [PMID: 33574907 DOI: 10.3892/etm.2021.9637] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Zittan E, Gralnek IM, Berns MS. The New Proactive Approach and Precision Medicine in Crohn's Disease. Biomedicines 2020;8:E193. [PMID: 32635316 DOI: 10.3390/biomedicines8070193] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Tieng FYF, Abu N, Sukor S, Mohd Azman ZA, Mahamad Nadzir N, Lee LH, Mutalib NSA. L1CAM, CA9, KLK6, HPN, and ALDH1A1 as Potential Serum Markers in Primary and Metastatic Colorectal Cancer Screening. Diagnostics (Basel) 2020;10:E444. [PMID: 32630086 DOI: 10.3390/diagnostics10070444] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
15 Jelski W, Mroczko B. Biochemical Markers of Colorectal Cancer - Present and Future.Cancer Manag Res. 2020;12:4789-4797. [PMID: 32606968 DOI: 10.2147/CMAR.S253369] [Cited by in Crossref: 8] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]